141 related articles for article (PubMed ID: 29967336)
1. Optimization of the diagnosis of inherited colorectal cancer using NGS and capture of exonic and intronic sequences of panel genes.
Baert-Desurmont S; Coutant S; Charbonnier F; Macquere P; Lecoquierre F; Schwartz M; Blanluet M; Vezain M; Lanos R; Quenez O; Bou J; Bouvignies E; Fourneaux S; Manase S; Vasseur S; Mauillon J; Gerard M; Marlin R; Bougeard G; Tinat J; Frebourg T; Tournier I
Eur J Hum Genet; 2018 Nov; 26(11):1597-1602. PubMed ID: 29967336
[TBL] [Abstract][Full Text] [Related]
2. Targeted deep-intronic sequencing in a cohort of unexplained cases of suspected Lynch syndrome.
Arnold AM; Morak M; Benet-Pagès A; Laner A; Frishman D; Holinski-Feder E
Eur J Hum Genet; 2020 May; 28(5):597-608. PubMed ID: 31822864
[TBL] [Abstract][Full Text] [Related]
3. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
[TBL] [Abstract][Full Text] [Related]
4. Screening for germline mutations in mismatch repair genes in patients with Lynch syndrome by next generation sequencing.
Soares BL; Brant AC; Gomes R; Pastor T; Schneider NB; Ribeiro-Dos-Santos Â; de Assumpção PP; Achatz MIW; Ashton-Prolla P; Moreira MAM
Fam Cancer; 2018 Jul; 17(3):387-394. PubMed ID: 28932927
[TBL] [Abstract][Full Text] [Related]
5. Germline Genetic Features of Young Individuals With Colorectal Cancer.
Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
[TBL] [Abstract][Full Text] [Related]
6. Molecular characteristics of young-onset colorectal cancer in Vietnamese patients.
Do MD; Nguyen TH; Le KT; Le LHG; Nguyen BH; Le KT; Doan TPT; Ho CQ; Nguyen HN; Tran TD; Vu HA
Asia Pac J Clin Oncol; 2022 Dec; 18(6):678-685. PubMed ID: 35098669
[TBL] [Abstract][Full Text] [Related]
7. Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testing.
Rohlin A; Rambech E; Kvist A; Törngren T; Eiengård F; Lundstam U; Zagoras T; Gebre-Medhin S; Borg Å; Björk J; Nilbert M; Nordling M
Fam Cancer; 2017 Apr; 16(2):195-203. PubMed ID: 27696107
[TBL] [Abstract][Full Text] [Related]
8. A molecular inversion probe-based next-generation sequencing panel to detect germline mutations in Chinese early-onset colorectal cancer patients.
Zhang J; Wang X; de Voer RM; Hehir-Kwa JY; Kamping EJ; Weren RDA; Nelen M; Hoischen A; Ligtenberg MJL; Hoogerbrugge N; Yang X; Yang Z; Fan X; Wang L; Liu H; Wang J; Kuiper RP; van Kessel AG
Oncotarget; 2017 Apr; 8(15):24533-24547. PubMed ID: 28445943
[TBL] [Abstract][Full Text] [Related]
9. Targeted next-generation sequencing of 22 mismatch repair genes identifies Lynch syndrome families.
Talseth-Palmer BA; Bauer DC; Sjursen W; Evans TJ; McPhillips M; Proietto A; Otton G; Spigelman AD; Scott RJ
Cancer Med; 2016 May; 5(5):929-41. PubMed ID: 26811195
[TBL] [Abstract][Full Text] [Related]
10. The Mendelian colorectal cancer syndromes.
Tomlinson I
Ann Clin Biochem; 2015 Nov; 52(Pt 6):690-2. PubMed ID: 26169059
[TBL] [Abstract][Full Text] [Related]
11. Genetic Testing for Hereditary Nonpolyposis Colorectal Cancer (HNPCC).
Nallamilli BRR; Hegde M
Curr Protoc Hum Genet; 2017 Jul; 94():10.12.1-10.12.23. PubMed ID: 28696559
[TBL] [Abstract][Full Text] [Related]
12. First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome.
Ziada-Bouchaar H; Sifi K; Filali T; Hammada T; Satta D; Abadi N
Fam Cancer; 2017 Jan; 16(1):57-66. PubMed ID: 27468915
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial and nuclear disease panel (Mito-aND-Panel): Combined sequencing of mitochondrial and nuclear DNA by a cost-effective and sensitive NGS-based method.
Abicht A; Scharf F; Kleinle S; Schön U; Holinski-Feder E; Horvath R; Benet-Pagès A; Diebold I
Mol Genet Genomic Med; 2018 Nov; 6(6):1188-1198. PubMed ID: 30406974
[TBL] [Abstract][Full Text] [Related]
14. Detecting clinically actionable variants in the 3' exons of PMS2 via a reflex workflow based on equivalent hybrid capture of the gene and its pseudogene.
Gould GM; Grauman PV; Theilmann MR; Spurka L; Wang IE; Melroy LM; Chin RG; Hite DH; Chu CS; Maguire JR; Hogan GJ; Muzzey D
BMC Med Genet; 2018 Sep; 19(1):176. PubMed ID: 30268105
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of CNV detection tools for NGS panel data in genetic diagnostics.
Moreno-Cabrera JM; Del Valle J; Castellanos E; Feliubadaló L; Pineda M; Brunet J; Serra E; Capellà G; Lázaro C; Gel B
Eur J Hum Genet; 2020 Dec; 28(12):1645-1655. PubMed ID: 32561899
[TBL] [Abstract][Full Text] [Related]
16. Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition.
Martin-Morales L; Rofes P; Diaz-Rubio E; Llovet P; Lorca V; Bando I; Perez-Segura P; de la Hoya M; Garre P; Garcia-Barberan V; Caldes T
PLoS One; 2018; 13(9):e0203885. PubMed ID: 30256826
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
Au CH; Wa A; Ho DN; Chan TL; Ma ES
Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
[TBL] [Abstract][Full Text] [Related]
19. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of germline pathogenic variants in Estonian colorectal cancer patients: results from routine clinical setting 2016-2021.
Roht L; Tooming M; Rekker K; Roomere H; Toome K; Murumets Ü; Šamarina U; Õunap K; Kahre T
Front Genet; 2022; 13():1020543. PubMed ID: 36425062
[No Abstract] [Full Text] [Related]
[Next] [New Search]
